Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
7.04
+0.13 (1.88%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Company Description
Tivic Health Systems, Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine.
Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus pain, pressure, and congestion.
The company sells its products on online retailers, commercial distributors, and through its own websites; The company’s lead product include Entolimo, a biologic program focuses on immunotherapeutics is the late-stage TLR5 agonist for the treatment of acute radiation syndrome.
In addition, it markets commercial product under the brand name ClearUP Sinus Pain Relief. It also focusses on non-invasive vagus nerve stimulation.
The company was incorporated in 2016 and is headquartered in Fremont, California.
Tivic Health Systems, Inc.
| Country | United States |
| Founded | 2016 |
| IPO Date | Nov 11, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Jennifer Ernst |
Contact Details
Address: 47685 Lakeview Blvd Fremont, California 94538 United States | |
| Phone | (888) 276-6888 |
| Website | tivichealth.com |
Stock Details
| Ticker Symbol | TIVC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001787740 |
| CUSIP Number | 888705100 |
| ISIN Number | US8887052095 |
| Employer ID | 81-4016391 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jennifer Ernst | Co-Founder, Chief Executive Officer and Director |
| Dr. Blake Gurfein Ph.D. | Chief Scientific Officer |
| Lisa G. Wolf | Interim Chief Financial Officer |
| Michael Kevin Handley | Chief Operating Officer and President of Tivic Biopharma |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2025 | 8-K | Current Report |
| Apr 14, 2025 | 8-K | Current Report |
| Apr 14, 2025 | 424B5 | Filing |
| Apr 10, 2025 | 8-K | Current Report |
| Apr 3, 2025 | 8-K | Current Report |
| Mar 21, 2025 | 10-K | Annual Report |
| Mar 21, 2025 | 8-K | Current Report |
| Mar 6, 2025 | 8-K | Current Report |
| Mar 5, 2025 | 8-K | Current Report |
| Feb 24, 2025 | 8-K | Current Report |